Thalassemia Minor: Diagnostic Workup and Management
Thalassemia minor requires no treatment and patients are asymptomatic, but definitive diagnosis through hemoglobin electrophoresis is essential to prevent unnecessary iron therapy and to provide genetic counseling. 1
Diagnostic Approach
Initial Laboratory Evaluation
Order a complete blood count with red cell indices as the first step; thalassemia minor characteristically shows microcytosis (low MCV, typically 60-70 fL) with a normal or near-normal RDW (≤14%), distinguishing it from iron deficiency anemia which shows RDW >14%. 1, 2
Calculate the Mentzer Index (MCV/RBC count): a value <13 strongly suggests thalassemia trait, while >13 favors iron deficiency anemia. 3
Measure serum ferritin and transferrin saturation to exclude coexisting iron deficiency; ferritin >30 µg/L with transferrin saturation >20% rules out iron deficiency, while ferritin <30 µg/L indicates true iron deficiency that may coexist with thalassemia trait. 1, 2
Confirmatory Testing
Hemoglobin electrophoresis is the definitive diagnostic test and should be ordered when microcytosis persists despite normal iron studies (ferritin >30 µg/L), when MCV is disproportionately low relative to hemoglobin, or when the patient has appropriate ethnic background (Mediterranean, African, or Southeast Asian ancestry). 1, 4
In β-thalassemia minor, hemoglobin electrophoresis reveals elevated HbA2 (>3.5%, typically 4-6%) and sometimes mildly elevated HbF (1-3%); normal HbA2 with microcytosis suggests α-thalassemia trait, which requires molecular genetic testing for confirmation. 4, 5
Molecular genetic testing using accurate circular consensus long-read sequencing should be considered when hemoglobin electrophoresis is inconclusive or when rare thalassemia variants are suspected, as this detects complex deletions and point mutations missed by conventional methods. 6
Management Principles
No Active Treatment Required
Thalassemia minor carriers are asymptomatic and do not require blood transfusions, chelation therapy, or any specific medical intervention; the condition represents a benign carrier state with normal life expectancy. 5
Iron supplementation should only be given if concurrent iron deficiency is documented (ferritin <30 µg/L or transferrin saturation <20%); thalassemia carriers are at the same risk of developing iron deficiency as the general population and require iron therapy when deficiency is proven. 5
Genetic Counseling and Family Screening
Provide genetic counseling to all confirmed carriers regarding the autosomal recessive inheritance pattern; if both partners are carriers of β-thalassemia, each pregnancy carries a 25% risk of thalassemia major, 50% risk of thalassemia minor, and 25% chance of being unaffected. 7
Screen the spouse or partner for thalassemia carrier status, particularly if the couple is of reproductive age or from a high-risk ethnic background; this is essential for assessing the risk of having a child with thalassemia major. 7, 8
Offer carrier screening to siblings and children of the proband, as they have a 50% chance of being carriers if one parent is affected. 7
Monitoring and Follow-Up
No routine hematologic monitoring is required for asymptomatic thalassemia minor carriers; however, periodic screening for iron deficiency is appropriate if symptoms of anemia develop or during pregnancy. 5
Screen for endocrine complications only in transfusion-dependent thalassemia; thalassemia minor does not cause iron overload or endocrinopathies and does not require endocrine surveillance. 9
Critical Pitfalls to Avoid
Do not prescribe iron supplementation based on microcytosis alone; always confirm iron deficiency with ferritin and transferrin saturation before starting iron therapy, as inappropriate iron supplementation in thalassemia carriers without true deficiency provides no benefit and may cause gastrointestinal side effects. 1, 5
Do not order hemoglobin electrophoresis as a first-line test; it is costly and unnecessary when iron studies are abnormal—first exclude iron deficiency, then proceed to electrophoresis if microcytosis persists with normal iron parameters. 1
Do not assume all microcytic anemia in patients of Mediterranean, African, or Southeast Asian descent is thalassemia; iron deficiency remains the most common cause of microcytosis worldwide and must be ruled out with ferritin and transferrin saturation. 1, 2
Do not overlook combined deficiencies; thalassemia minor can coexist with iron, vitamin B12, or folate deficiency, recognizable by an elevated RDW despite the underlying thalassemia trait. 1
Do not delay partner screening in couples planning pregnancy; preconception carrier screening allows for informed reproductive decisions and prenatal diagnosis options if both partners are carriers. 8